FDA Adverse Event Injury Summary report: N

SYNCHROMED II

MDR report key: 3811394 · Received May 15, 2014

Report

Report Number
3004209178-2014-08956
Event Type
Injury
Date Received
May 15, 2014
Date of Event
April 18, 2014
Report Date
April 19, 2014
Manufacturer
MEDTRONIC PUERTO RICO OPERATIONS CO.
Product Code
LKK
PMA / PMN Number
P860004
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
VA, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

CONCOMITANT PRODUCTS: PRODUCT ID 8840, SERIAL # UNKNOWN, PRODUCT TYPE PROGRAMMER, PHYSICIAN; PRODUCT ID 8709, LOT # J10811R38, IMPLANTED: (B)(6) 2001, PRODUCT TYPE CATHETER; PRODUCT ID 8578, SERIAL # (B)(4), IMPLANTED: (B)(6) 2014, PRODUCT TYPE ACCESSORY. (B)(4).

Description of Event or Problem · 1

IT WAS REPORTED THAT FOLLOWING A ROUTINE PUMP REPLACEMENT PROCEDURE THE PATIENT BECAME LETHARGIC AND WAS ADMITTED TO THE HOSPITAL; THEY WERE SUSPECTING ACUTE RENAL FAILURE. THE ROUTINE PUMP REPLACEMENT WAS UNEVENTFUL. THE OLD PUMP WAS PROGRAMMED TO DELIVER DILAUDID (10MG/ML AT 6.98MG/DAY), BUPIVACAINE (30MG/ML AT 20.96MG/DAY), AND CLONIDINE (60MCG/ML AT 41.92MCG/DAY). THE NEW PUMP WAS PROGRAMMED THE SAME; HOWEVER, UPON FURTHER REVIEW OF THE MEDICATION THE NEW PUMP WAS FILLED WITH DILAUDID (20MG/ML), BUPIVACAINE (30MG/ML), AND CLONIDINE (120MCG/ML), SO THE PUMP WAS DELIVERING A DOUBLE DOSE OF THE CLONIDINE AND DILAUDID. THE PHYSICIAN OPTED TO REDUCE THE INTENDED DOSE (6.98MG/DAY) BY 10% TO 6.282MG/DAY. THE PATIENT HAD BEEN RECEIVING TWICE THE DOSE OF CLONIDINE AND DILAUDID FOR APPROXIMATELY 24 HOURS BEFORE THE PROGRAMMING WAS CORRECTED. IT WAS LATER REPORTED THAT THE PATIENT WAS DOING FINE NOW. THIS REPORTER DID NOT KNOW IF THE PATIENT HAD RENAL FAILURE. THE PATIENT HAD SOME OTHER ISSUES UNRELATED TO THE PUMP, BUT WAS DOING FINE NOW.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
290485 SYNCHROMED II PUMP, INFUSION, IMPLANTED, PROGRAMMABLE LKK MEDTRONIC PUERTO RICO OPERATIONS CO. 8637-40

Patients

Seq Age Sex Outcome Treatment
1 00056 YR Hospitalization| R